Bionor Pharma ASA's Phase II Vacc-4x Data Published In /i

Bionor Pharma ASA announces that the results from the randomized, multicenter, double-blinded, placebo-controlled Phase II trial with 135 patients of the Company's lead candidate Vacc-4x will be published in The Lancet Infectious Diseases and available online at www.thelancet.com as of today.

http://ift.tt/1eO5DuB